Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ-Reference-Cited by-同舟云学术

Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ

Published:2017-01-12 Issue:1 Volume:12 Page:e0169957
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Libertinova Jana,Meluzinova Eva,Tomek Ales,Horakova Dana,Kovarova Ivana,Matoska Vaclav,Kumstyrova Simona,Zajac Miroslav,Hyncicova Eva,Liskova Petra,Houzvickova Eva,Martinkovic Lukas,Bojar Martin,Havrdova Eva,Marusic Petr

Funder

IGA MZ CR

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference32 articles.

1. Defining interferon beta response status in multiple sclerosis patients;RA Rudick;Ann Neurol,2004

2. Biological monitoring of IFN-β therapy in Multiple Sclerosis;A Bertolotto;Cytokine and Growth Factor Rev,2015

3. Control of IFN-inducible MxA gene expression in human cells;T Ronni;J Immunol,1993

4. Lack of IFN-beta bioactivity is associated with the occurence of relapses in multiple sclerosis;LF van der Voort;Eur J Neurol,2009

5. Predictive markers for response to interferon therapy in patients with multiple sclerosis;S Malucchi;Neurology,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs are dysregulated in peripheral blood mononuclear cells in multiple sclerosis and correlate with T cell mediators;Journal of Neuroimmunology;2024-01

2. A long-term follow-up study on biochemical and clinical biomarkers of response to interferon beta-1b treatment in relapsing-remitting multiple sclerosis;Advances in Clinical and Experimental Medicine;2020-06-05